Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
AbstractBackground. High-dose chemotherapy (HDC) with hematopoietic progenitor cell transplantation is a standard option for relapsed/refractory testicular ger
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 May 2017
|
| In: |
Annals of oncology
Year: 2017, Volume: 28, Issue: 8, Pages: 1910-1916 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx259 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1093/annonc/mdx259
|
| Author Notes: | U. De Giorgi, S. Richard, M. Badoglio, E. Kanfer, J.H. Bourrhis, E. Nicolas-Virelizier, K. Vettenranta, B. Lioure, S. Martin, P. Dreger, M.K. Schuler, K. Thomson, E. Scarpi, G. Rosti, F. Selle, G. Mangili, F. Lanza, & M. Bregni , on behalf of the Solid Tumours Working Party (STWP) of the EBMT |
| Summary: | AbstractBackground. High-dose chemotherapy (HDC) with hematopoietic progenitor cell transplantation is a standard option for relapsed/refractory testicular ger |
|---|---|
| Item Description: | Gesehen am 29.08.2018 |
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdx259 |